Sign In
Buy IVC
$0.660
+0 (+0%)
At Close: Apr 28, 2023
Invacare (IVC) Reports Q3 Loss, Misses Revenue Estimates
11:45pm, Monday, 07'th Nov 2022 Zacks Investment Research
Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare (IVC) Reports Q3 Loss, Misses Revenue Estimates
08:19pm, Monday, 07'th Nov 2022
Invacare (IVC) delivered earnings and revenue surprises of -45.95% and 13.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare Reports Results for Third Quarter 2022
04:15pm, Monday, 07'th Nov 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended September 30, 2022.
Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results
08:00am, Thursday, 20'th Oct 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 202
Invacare Corporation Announces Additional Draw of Term Loans and Exchange of Existing Convertible Notes
04:20pm, Monday, 03'rd Oct 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announced today the consummation of additional draws of an aggregate of $18,500,000 of term loans p
Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule
04:26pm, Thursday, 29'th Sep 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced that it received notice from the New York Stock Exchange (the “NYSE”) that the company is not in compliance with Sec
Invacare Corporation Announces Executive Leadership Changes
07:35am, Monday, 29'th Aug 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced changes to its senior management team and Board of Directors to advance its previously announced business transformation
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
09:56am, Wednesday, 24'th Aug 2022 Benzinga
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares jumped 55.2% to close at $0.70 on Tuesday after the company announced it has entered into a global licensing agreement for the development an
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
04:14pm, Tuesday, 23'rd Aug 2022 Benzinga
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares surged 60.5% to $0.7238 after the company announced it has entered into a global licensing agreement for the development and commercializatio
Invacare Corporation Announces Cooperation Agreement With Azurite Management
04:15pm, Monday, 22'nd Aug 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC (“Azurite”), w
Invacare Corporation's (IVC) CEO Matt Monaghan on Q2 2022 Results - Earnings Call Transcript
10:25am, Tuesday, 09'th Aug 2022
Invacare Corporation (NYSE:IVC ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Lois Lee - Director of Treasury, Investor Relations and Corporate Communications Matt M
Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates
11:25pm, Monday, 08'th Aug 2022 Zacks Investment Research
Invacare (IVC) delivered earnings and revenue surprises of -20.45% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare (IVC) Reports Q2 Loss, Lags Revenue Estimates
09:04pm, Monday, 08'th Aug 2022
Invacare (IVC) delivered earnings and revenue surprises of -20.45% and 11.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Invacare Reports Results for Second Quarter 2022
04:20pm, Monday, 08'th Aug 2022
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2022. Executive Summary Reflecting on the quarter, M
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Surpass Estimates
11:15am, Thursday, 28'th Jul 2022 Zacks Investment Research
West Pharmaceutical (WST) delivered earnings and revenue surprises of 12.79% and 2.44%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
